How universal is the fractional-quantum-Hall edge Luttinger liquid?

This article reports on our microscopic investigations of the edge of the fractional quantum Hall state at filling factor $\nu=1/3$. We show that the interaction dependence of the wave function is well described in an approximation that includes mixing with higher composite-fermion Landau levels in the lowest order. We then proceed to calculate the equal time edge Green function, which provides evidence that the Luttinger exponent characterizing the decay of the Green function at long distances is interaction dependent. The relevance of this result to tunneling experiments is discussed.Comment: 5 page

Mojave Applied Ecology Notes Winter 2011

Lake Mead’s collaborative applied science research program; “annoying the elephant” - ruminations on active management by Alice Newton, Lake Mead NRA vegetation manager; 2012 NWRA Lake Mead symposium sneak peak; assessing forest change using dendrochronology in the Spring Mountains

Mapping the Archaeology of Somaliland: Religion, Art, Script, Time, Urbanism, Trade and Empire

FdA – Publicaties zonder aanstelling Universiteit LeidenHeritage of Indigenous People

Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting Anti-Retroviral Drugs for Treating HIV-1

BACKGROUND: Humanized mice generate a lymphoid system of human origin subsequent to transplantation of human CD34+ cells and thus are highly susceptible to HIV infection. Here we examined the efficacy of antiretroviral treatment (ART) when added to food pellets, and of long-acting (LA) antiretroviral compounds, either as monotherapy or in combination. These studies shall be inspiring for establishing a gold standard of ART, which is easy to administer and well supported by the mice, and for subsequent studies such as latency. Furthermore, they should disclose whether viral breakthrough and emergence of resistance occurs similar as in HIV-infected patients when ART is insufficient. METHODS/PRINCIPAL FINDINGS: NOD/shi-scid/γ(c)null (NOG) mice were used in all experimentations. We first performed pharmacokinetic studies of the drugs used, either added to food pellets (AZT, TDF, 3TC, RTV) or in a LA formulation that permitted once weekly subcutaneous administration (TMC278: non-nucleoside reverse transcriptase inhibitor, TMC181: protease inhibitor). A combination of 3TC, TDF and TMC278-LA or 3TC, TDF, TMC278-LA and TMC181-LA suppressed the viral load to undetectable levels in 15/19 (79%) and 14/14 (100%) mice, respectively. In successfully treated mice, subsequent monotherapy with TMC278-LA resulted in viral breakthrough; in contrast, the two LA compounds together prevented viral breakthrough. Resistance mutations matched the mutations most commonly observed in HIV patients failing therapy. Importantly, viral rebound after interruption of ART, presence of HIV DNA in successfully treated mice and in vitro reactivation of early HIV transcripts point to an existing latent HIV reservoir. CONCLUSIONS/SIGNIFICANCE: This report is a unique description of multiple aspects of HIV infection in humanized mice that comprised efficacy testing of various treatment regimens, including LA compounds, resistance mutation analysis as well as viral rebound after treatment interruption. Humanized mice will be highly valuable for exploring the antiviral potency of new compounds or compounds targeting the latent HIV reservoir